David Schenkein - Director at Regeneron Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
REGN on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by David Schenkein since 7/5/2023

Holdings reported by David Schenkein for Regeneron Pharmaceuticals, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 282 $268 K $951.26 Jan 2, 2024 Direct
Non-Qualified Stock Option (right to buy) 508 Jan 2, 2024 Direct Common Stock

Transactions reported by David Schenkein for Regeneron Pharmaceuticals, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership